NCT05468450View on ClinicalTrials.gov

RCT Comparing EVLA Versus Polidocanol Foam in the Treatment of SSV Insufficiency

NACompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

July 1, 2015

Primary Completion Date

August 31, 2016

Study Completion Date

August 31, 2016

Conditions
Varicose Veins of Lower Limb
Interventions
DRUG

Ultrasound-guided-foam sclerotherapy (UGFS) using Polidocanol sclerosant

Direct injection Foam sclerotherapy

DEVICE

Endovenous Laser Ablation (EVLA)

EVLA using a 1470nm generator and 600-micron radial fibres (Biolitec® Biomedical Technology, Jena, Germany), under tumescent local anaesthesia (TLA)

All Listed Sponsors
lead

Societe Francaise de Phlebologie

OTHER

NCT05468450 - RCT Comparing EVLA Versus Polidocanol Foam in the Treatment of SSV Insufficiency | Biotech Hunter | Biotech Hunter